Filing Flows › Comparisons › TXMD vs NWBO
TherapeuticsMD vs Northwest Biotherapeutics: TXMD and NWBO compared
TherapeuticsMD is the larger company: $869K of revenue in its latest quarter (Q2 2026) against $807K for Northwest Biotherapeutics (Q2 2026). Northwest Biotherapeutics is growing faster (+516% against -9% a year earlier).
Where the money goes: TXMD and NWBO
TherapeuticsMD (TXMD) · Q2 2026
TherapeuticsMD, Q2 2026: revenue $869K (-9% year over year), operating margin -93.9%, net earnings $155K, operating cash flow $779K. The chart follows the revenue to costs, profit and cash.
Northwest Biotherapeutics (NWBO) · Q2 2026
Northwest Biotherapeutics, Q2 2026: revenue $807K (+516% year over year), net loss $15.4M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
| TherapeuticsMD (TXMD) | Northwest Biotherapeutics (NWBO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $869K | $807K |
| Revenue growth, Y/Y | -9% | +516% |
| Operating margin | -93.9% | n/m |
| Net earnings | $155K | −$15.4M |
| Net margin | 17.8% | — |
| Operating cash flow | $779K | −$7.2M |
Questions
Which is bigger, TherapeuticsMD or Northwest Biotherapeutics?
TherapeuticsMD is the larger company: $869K of revenue in its latest quarter (Q2 2026) against $807K for Northwest Biotherapeutics (Q2 2026).
Is TherapeuticsMD or Northwest Biotherapeutics growing faster?
Northwest Biotherapeutics is growing faster (+516% against -9% a year earlier).
More: TherapeuticsMD earnings · how TherapeuticsMD makes money · Northwest Biotherapeutics earnings · how Northwest Biotherapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.